Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON28994Completed
Trial of methylphenidate and sulpiride (3 arms), sponsored by Radboud University. Primary endpoints: Baseline dopamine synthesis capacity, BOLD signal and 4 more. Started Feb 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON28994.